BLOCK LISTING SIX MONTHLY RETURN
(Note: Italicised terms have the same meaning as given in the Listing Rules.)
Date: 1 November 2021
| Name of applicant: | AMTE Power plc | |||
| Name of scheme: | Enterprise Management Incentive Scheme, warrants and unapproved share option plan | |||
| Period of return: | From: | 12 Mar 2021 | To: | 31 Oct 2021 |
| Balance of unallotted securities under scheme(s) from previous return: | 2,551,924 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 96,923 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 1,045,407 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 1,603,440 | |||
| Name of contact: | Kevin Brundish / James Hobson |
| Telephone number of contact: | +44 (0) 1847 867 200 |
Notes to Editors:
AMTE Power was founded in 2013 and is a leading developer and manufacturer of lithium-ion battery cells for specialist markets. In March 2021, the Company listed on the AIM market of the London Stock Exchange. The Company is focused on launching a series of next generation battery cells based on new chemistries and cell structures that are designed to solve key problems in power delivery, energy performance, and safety. These new products are targeted at a range of specialist markets including the automotive industry, oil and gas market and energy storage sector. AMTE's purpose-built cell manufacturing facility in Thurso, Scotland has the second largest cell manufacturing capacity in the UK and the Company also has a product development team based in Oxford. For further information visit the Company's website: www.amtepower.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
